Kristina Hamilton wants to warn others as she continues to fight diffuse systemic scleroderma, with which she was diagnosed ...

Systemic sclerosis (SSc), also referred to as scleroderma, is a rare autoimmune disease associated with vasculopathy, inflammation, and fibrosis of the skin and/or internal organs. Interstitial lung ...

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, found no clear association between immunosuppressive or anti-fibrotic medications and ...

Although less common than other subtypes of systemic sclerosis (SSc), systemic sclerosis sine scleroderma (ssSSc) makes up more than 8% of SSc cases and "should not be neglected," according to a new ...

Scleroderma is an autoimmune condition of unknown aetiology with a range of manifestations, which can be limited to the skin or can extend to be multisystemic. It is characterised by fibrosis, ...

Systemic sclerosis, or scleroderma, causes the hardening of skin and connective tissues. Often, the disease harms other organs, such as the heart, kidneys, lungs, and gastrointestinal tract, and it ...

Clinically significant ES among patients with SSc appear to be decreasing over time, occurring later in the disease course, and show no impact on overall survival.

Phase 1/2 SSc study is expected to enroll patients at over 20 participating clinical sites in at least five countriesRecently completed Phase 1 ...

By Karen Roman Prolium Bioscience, Inc. said it dosed its first patient in Phase 1/2 study of PRO-203, a T-cell engager treatment for systemic sclerosis, following the completion of a study in 20 ...

Systemic sclerosis (SSc) is a rare autoimmune disease that can harden the skin, impair blood flow, and damage internal organs such as the lungs and kidneys. But no two patients experience the disease ...